Search

Home > News & Events > Current News
26 March 2020 Notice to SATVI study participants: COVID-19 Lockdown
Thu, 26 Mar 2020 - 18:30

Due to the lockdown announced by the South African President, we want to bring the following information to the attention of all participants in SATVI studies.

15 March 2020 Research Blood transcriptional signatures for tuberculosis testing
Sat, 21 Mar 2020 - 20:30

Professors Mark Hatherill, Tom Scriba, Doctors Simon Mendelsohn & Mbandi have authored an article titled: "Blood transcriptional signatures for tuberculosis testing" appearing in the Lancet Respiratory Medicine

4 March 2020 Best paper award for UCT TB vaccine research
Sat, 07 Mar 2020 - 09:00

A paper which UCT’s Professors Mark Hatherill, Robert Wilkinson, Tom Scriba, Drs. Michèle Tameris and Friedrich Thienemann played a key role, has been selected as the best paper of the year for 2019. 

2 March 2020 - Clinical Development of New TB Vaccines: Recent Advances and Next Steps.
Thu, 05 Mar 2020 - 22:30

Professor Mark Hatherill has co-authored a journal article titled: "Clinical Development of New TB Vaccines: Recent Advances and Next Steps" appearing in the Frontiers in Microbiology journal. 

22 February 2020 Research: Immune correlates of tuberculosis disease and risk translate across species.
Sun, 23 Feb 2020 - 11:30

SATVI researchers Professor Tom Scriba and Doctor Stanley Kimbung Mbandi have co-authored an article titled "Immune correlates of tuberculosis disease and risk translate across species" appearing in the Science Translational Medicine journal.

21 January 2020 Research: Headway made towards biosignatures for tuberculosis incipient
Tue, 21 Jan 2020 - 15:00

Professor Tom Scriba and Dr Simon Mendelsohn have published a journal article titled: "Making headway towards biosignatures for incipient tuberculosis" appearing in the Lancet Respiratory Medicine. 

2 December 2019: EDCTP funded clinical trial testing new tuberculosis vaccine initiates vaccinations
Wed, 18 Dec 2019 - 08:45

The Prevention of Recurrence (POR) Consortium has been awarded a substantial grant from the European & Developing Countries Clinical Trial Partnership (EDCTP) which will support a clinical trial in South Africa and Tanzania of a new and promising tuberculosis (TB) vaccine candidate H56:IC31, developed by the Statens Serum Institute (SSI). 

22 November 2019 Research Preferred product characteristics for therapeutive vaccines
Fri, 22 Nov 2019 - 13:45

Professor Mark Hatherill has co-authored a journal article titled: "Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organisation consultations" appearing in the Vaccine journal.

14 November 2019 Research: Book Chapter: Diagnosing childhood tuberculosis during a vaccine trial in South Africa.
Thu, 14 Nov 2019 - 22:45

Dr Michèle Tameris, has co-authored a book chapter titled "Between representing and intervening: Diagnosing childhood tuberculosis during a vaccine trial in South Africa".

SATVI researcher Dr Luabeya awarded ‘C’ rating from the South African National Research Foundation.
Wed, 13 Nov 2019 - 15:45

Dr Angelique Luabeya has been awarded "C" rating from the National Research Foundation.

4 November 2019 SATVI Senior Research officer Elisa Nemes promoted to Associate Professor
Mon, 04 Nov 2019 - 15:30

The interim Dean of the UCT Faculty of Health Sciences has just announced that SATVI Senior Research Officer, Elisa Nemes has been promoted to Associate Professor. 

30 October 2019 Press Conference:Final results M72/AS01E candidate vaccine
Wed, 30 Oct 2019 - 19:30

TB Science Official Press Conference: Watch announcement  of final results from M72/AS01E candidate vaccine against tuberculosis (TB) online.

Pages